NEW YORK, June 18, 2018 /CNW/ — Pomerantz LLP is
investigating claims on behalf of investors of Catalyst Biosciences, Inc. (“Catalyst” or the “Company”) (NASDAQ:
CBIO). Such investors are advised to contact Robert S. …
Go to Source